Citation tools
"Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.." The Journal of Rheumatology
34.3
(2007):
623-633.
Web. 24 April. 2024.